Glenmark Pharmaceuticals Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, Securing 180-Day Exclusivity
Glenmark Specialty SA has received final U.S. FDA approval for its Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. The…